ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,00%
Dow Jones
39 387,76
0,85%
DAX
18 679,71
0,00%
Brent Oil
84,21
0,31%
Bitcoin
63 046,43
0,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Jaguar Health Inc (JAGX)

  7. Jaguar Health Inc (JAGX) Actualités

JAGX

Jaguar Health (JAGX)

Jaguar Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:JAGX
DateHeureSourceTitreSymboleSociété
08/03/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAGXJaguar Health Inc
05/03/202413h00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JAGXJaguar Health Inc
30/11/202314h10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:JAGXJaguar Health Inc
15/11/202303h00PR Newswire (Canada)FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTSNASDAQ:JAGXJaguar Health Inc
21/09/202313h30PR Newswire (Canada)FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERUNASDAQ:JAGXJaguar Health Inc
14/08/202322h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAGXJaguar Health Inc
14/08/202322h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:JAGXJaguar Health Inc
01/06/202312h01Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:JAGXJaguar Health Inc
31/05/202323h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:JAGXJaguar Health Inc
19/05/202323h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JAGXJaguar Health Inc
19/05/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JAGXJaguar Health Inc
16/05/202323h30Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:JAGXJaguar Health Inc
15/05/202323h11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:JAGXJaguar Health Inc
15/05/202314h35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JAGXJaguar Health Inc
28/04/202322h42Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:JAGXJaguar Health Inc
14/02/202322h28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JAGXJaguar Health Inc
10/01/202314h30PR Newswire (Canada)Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health IllnessesNASDAQ:JAGXJaguar Health Inc
16/12/202212h01Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:JAGXJaguar Health Inc
02/09/202218h10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:JAGXJaguar Health Inc
26/08/202216h59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JAGXJaguar Health Inc
16/08/202222h32Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:JAGXJaguar Health Inc
09/06/202214h30PR Newswire (Canada)Filament Health and Jaguar Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health IndicationsNASDAQ:JAGXJaguar Health Inc
23/05/202214h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:JAGXJaguar Health Inc
11/03/202222h34Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JAGXJaguar Health Inc
10/12/202123h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:JAGXJaguar Health Inc
07/12/202123h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:JAGXJaguar Health Inc
22/11/202123h31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:JAGXJaguar Health Inc
06/09/202108h04TipRanksJaguar Health Announces 1-for-3 Reverse Stock Split; Shares Drop 13.8%NASDAQ:JAGXJaguar Health Inc
16/08/202110h02TipRanksJaguar Health Q2 Results Miss Estimates; Shares Fall 6.8%NASDAQ:JAGXJaguar Health Inc
09/04/202122h07Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)NASDAQ:JAGXJaguar Health Inc
 Showing the most relevant articles for your search:NASDAQ:JAGX

Dernières Valeurs Consultées

EU
HO
Thales
NYSE
MRK
Merck
EU
ML
Michelin
USI
USTECH100
US Tech 100
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
CAP
Capgemini
EU
DG
Vinci
EU
VK
Vallourec
EU
EN
Bouygues
COIN
BTCUSD
Bitcoin
EU
CS
Axa
EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés